Surrey Heartlands

Joint Formulary & PAD

Bisacodyl - Constipation

You are here : Home > Formulary Search > Bisacodyl - Constipation

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Suppositories
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important
NOTE - 7.5mg suppositories are non-formulary. Only the licensed 5mg and 10mg suppositories should be prescribed
 

Status 2

Non Formulary
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important
7.5mg suppositories are unlicensed and not approved for use in Surrey Heartlands.
Documents :
 
Policy Statement
Aralax Suppositories for constipation - Policy Statement PCN 78-2013 - Nov 2013
Evidence Review
Aralax Suppositories - Evidence Review - November 2013

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Bisacodyl
Indication :
Constipation
Group Name :
Keywords :
Stimulant laxatives
Brand Names Include :
Dulcolax,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Constipation
Supporting Documents :
2
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Bisacodyl is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Constipation.

Committee Recommendations (2)

03 Jul 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.

Management | Constipation | CKS | NICE

The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.

Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.

02 Dec 20 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

NOTE -  In October 2019 bisacodyl 7.5mg suppositories (Aralax) are NOT locally recommended. They are unlicensed and have been assigned a NON FORMULARY traffic light status. For more information visit the Aralax profile on PAD. https://surreyccg.res-systems.net/PAD/Search/DrugConditionProfile/4822